MedPath

A Clinical Study to compare the effects of Grivabasti with Prasarini Taila and Baladi Kwath orally in patients suffering from uncomplicated Manyastambha(Cervical Spondylosis)

Phase 2
Conditions
Health Condition 1: M190- Primary osteoarthritis of other joints
Registration Number
CTRI/2023/11/059559
Lead Sponsor
Dr Sabrina Yasmin Barbhuiya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

•Patients of either sex with presenting symptoms of cervical spondylosis and fulfilling the diagnostic criteria.

•Age group between 18 years to 60 years.

•Clinical symptoms with or without radiological.

Exclusion Criteria

•Stenosis of the spinal canal.

•Cervical injury.

•Myelopathy.

•Autoimmune/ inflammatory diseases- Rheumatoid arthritis, SLE, Ankylosing spondylitis etc.

•Any acute or chronic systemic disease.

•Pregnant lady and lactating mother.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Relief in presenting symptoms of Cervical Spondylosis. <br/ ><br> 2.Improvement in Visual Analogue Scale(VAS) for pain. <br/ ><br> 3.Improvement in Neck Disability Index(NDI) Score and Disability level.Timepoint: 15th day, 30th day, 60th day, 90th day
Secondary Outcome Measures
NameTimeMethod
Complete absence of presenting symptoms of Cervical SpondylosisTimepoint: 15th day, 30th day, 60th day, 90th day
© Copyright 2025. All Rights Reserved by MedPath